{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T21:17:51Z","timestamp":1773004671787,"version":"3.50.1"},"reference-count":70,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.ijpharm.2018.08.028","type":"journal-article","created":{"date-parts":[[2018,8,17]],"date-time":"2018-08-17T13:18:17Z","timestamp":1534511897000},"page":"24-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Enhanced oral bioavailability and anti-gout activity of [6]-shogaol-loaded solid lipid nanoparticles"],"prefix":"10.1016","volume":"550","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2186-4249","authenticated-orcid":false,"given":"Qilong","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuxuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7451-0466","authenticated-orcid":false,"given":"Xia","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuyu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caleb K.","family":"Firempong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ximing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenwen","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangnan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2018.08.028_b0005","doi-asserted-by":"crossref","first-page":"327","DOI":"10.4142\/jvs.2006.7.4.327","article-title":"Pharmacokinetics and bioavailability of doxycycline in ostriches (Struthio camelus) at two different dose rates","volume":"7","author":"Abu-Basha","year":"2006","journal-title":"J. Vet. Sci."},{"key":"10.1016\/j.ijpharm.2018.08.028_b0010","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.biopha.2017.12.009","article-title":"[6]-Shogaol attenuates inflammation, cell proliferation via modulate NF-\u03baB and AP-1 oncogenic signaling in 7,12-dimethylbenz[a]anthracene induced oral carcinogenesis","volume":"98","author":"Annamalai","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"9","key":"10.1016\/j.ijpharm.2018.08.028_b0015","first-page":"568","article-title":"Effect of formulation compositions on particle size and zeta potential of diclofenac sodium-loaded chitosan nanoparticles","volume":"7","author":"Asasutjarit","year":"2013","journal-title":"Int. J. Pharmacol. Pharmaceut. Sci."},{"key":"10.1016\/j.ijpharm.2018.08.028_b0020","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1517\/17425247.2012.673278","article-title":"Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery","volume":"9","author":"Battaglia","year":"2012","journal-title":"Expert. Opin. Drug Deliv."},{"issue":"1","key":"10.1016\/j.ijpharm.2018.08.028_b0025","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3899\/jrheum.170137","article-title":"Corticosteroid or nonsteroidal antiinflammatory drugs for the treatment of acute gout: a systematic review of randomized controlled trials","volume":"45","author":"Billy","year":"2018","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.ijpharm.2018.08.028_b0030","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3109\/10837450.2014.971378","article-title":"Evaluation of nicotinamide microemulsion on the skin penetration enhancement","volume":"21","author":"Boonme","year":"2016","journal-title":"Pharma. Dev. Technol."},{"issue":"4","key":"10.1016\/j.ijpharm.2018.08.028_b0035","first-page":"779","article-title":"The preparation of the sustained release metformin hydrochloride microcapsules by the Wurster fluidized bed","volume":"27","author":"Cao","year":"2014","journal-title":"Pakistan J. Pharma. Sci."},{"key":"10.1016\/j.ijpharm.2018.08.028_b0040","first-page":"753","article-title":"In vitro release and in vitro-in vivo correlation for silybin meglumine incorporated into hollow-type mesoporous silica nanoparticles","volume":"7","author":"Cao","year":"2012","journal-title":"Int. J. Nanomed."},{"issue":"1\u20132","key":"10.1016\/j.ijpharm.2018.08.028_b0045","first-page":"64","article-title":"Seventy-two-hour release formulation of the poorly soluble drug silybin based on porous silica nanoparticles: in vitro release kinetics and in vitro\/in vivo correlations in beagle dogs","volume":"48","author":"Cao","year":"2013","journal-title":"Eur. J. Pharma. Sci. Off. J. Eur. Federat. Pharma. Sci."},{"issue":"1","key":"10.1016\/j.ijpharm.2018.08.028_b0050","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jep.2012.10.043","article-title":"Fresh ginger (Zingiber officinale) has anti-viral activity against human respiratory syncytial virus in human respiratory tract cell lines","volume":"145","author":"Chang","year":"2013","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ijpharm.2018.08.028_b0060","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jconrel.2017.01.039","article-title":"ApoE-modified solid lipid nanoparticles: a feasible strategy to cross the blood-brain barrier","volume":"249","author":"Dal Magro","year":"2017","journal-title":"J. Controll. Release: Off. J. Controll. Release Soc."},{"key":"10.1016\/j.ijpharm.2018.08.028_b0065","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2015-209109","article-title":"Allopurinol dose relative to renal function and risk of hypersensitivity reactions","author":"Day","year":"2016","journal-title":"Ann. Rheumat. Dis."},{"issue":"3","key":"10.1016\/j.ijpharm.2018.08.028_b0070","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0254-6272(15)30097-2","article-title":"Effect of Sanhuangwuji powder, anti-rheumatic drugs, and ginger-partitioned acupoint stimulation on the treatment of rheumatoid arthritis with peptic ulcer: a randomized controlled study","volume":"35","author":"Defang","year":"2015","journal-title":"J. Tradit. Chin. Med."},{"key":"10.1016\/j.ijpharm.2018.08.028_b0075","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1166\/jbn.2012.1420","article-title":"Comparison of pharmacokinetic profiles of PM02734 loaded lipid nanoparticles and cyclodextrins. in vitro and in vivo characterization","volume":"8","author":"De Mendoza","year":"2012","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.ijpharm.2018.08.028_b0080","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2174\/157341309788921516","article-title":"Lipid matrix nanoparticles: pharmacokinetics and biopharmaceutics","volume":"5","author":"Doktorovova","year":"2009","journal-title":"Curr. Nanosci."},{"key":"10.1016\/j.ijpharm.2018.08.028_b0085","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jddst.2017.02.001","article-title":"Enhancing bioavailability and controlling the release of glibenclamide from optimized solid lipid nanoparticles","volume":"38","author":"Elbahwy","year":"2017","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijpharm.2018.08.028_b0090","first-page":"25","article-title":"Febuxostat: the evidence for its use in the treatment of hyperuricemia and gout","volume":"4","author":"Gaffo","year":"2009","journal-title":"Core Evidence"},{"key":"10.1016\/j.ijpharm.2018.08.028_b0095","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jconrel.2014.04.032","article-title":"A novel strategy for the treatment of chronic wounds based on the topical administration of rhEGF-loaded lipid nanoparticles: in vitro bioactivity and in vivo effectiveness in healing-impaired db\/db mice","volume":"185","author":"Gainza","year":"2014","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.ijpharm.2018.08.028_b0100","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ejpb.2014.05.004","article-title":"Solid lipid nanoparticles as vehicles of drugs to the brain: current state of the art","volume":"87","author":"Gastaldi","year":"2014","journal-title":"Eur. J. Pharmaceut. Biopharmaceut.: off. J. Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V"},{"key":"10.1016\/j.ijpharm.2018.08.028_b0105","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/25\/27\/275103","article-title":"Two cholesterol derivative-based PEGylated liposomes as drug delivery system, study on pharmacokinetics and drug delivery to retina","volume":"25","author":"Geng","year":"2014","journal-title":"Nanotechnology"},{"issue":"4","key":"10.1016\/j.ijpharm.2018.08.028_b0110","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.vph.2005.07.003","article-title":"Cardiovascular effects of ginger aqueous extract and its phenolic constituents are mediated through multiple pathways","volume":"43","author":"Ghayur","year":"2005","journal-title":"Vascul. Pharmacol."},{"key":"10.1016\/j.ijpharm.2018.08.028_b0115","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1038\/s41598-017-04036-6","article-title":"Hyperuricemia and overexcretion of uric acid increase the risk of simple renal cysts in type 2 diabetes","volume":"Vol. 7","author":"Han","year":"2017","journal-title":"Scien. Rep."},{"issue":"3","key":"10.1016\/j.ijpharm.2018.08.028_b0120","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3233\/JND-170223","article-title":"Development of a new self-reporting instrument measuring benefits and side effects of corticosteroids in duchenne muscular dystrophy: report from a pilot study","volume":"4","author":"Hendriksen","year":"2017","journal-title":"J. Neuromuscul. Dis."},{"issue":"1","key":"10.1016\/j.ijpharm.2018.08.028_b0125","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.bbrc.2007.08.012","article-title":"Ginger ingredients reduce viability of gastric cancer cells via distinct mechanisms","volume":"362","author":"Ishiguro","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijpharm.2018.08.028_b0135","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ijbiomac.2016.07.020","article-title":"Optimization & design of isradipine loaded solid lipid nanobioparticles using rutin by Taguchi methodology","volume":"92","author":"Kumar","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijpharm.2018.08.028_b0140","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jep.2015.08.016","article-title":"Safety assessment of saponins extract in Dolichos falcatus Klein: subchronic study in Sprague-Dawley rats","volume":"174","author":"Lan","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ijpharm.2018.08.028_b0145","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.renene.2018.04.010","article-title":"Span80\/Tween80 stabilized bio-oil-in-diesel microemulsion: Formation and combustion","volume":"126","author":"Liang","year":"2018","journal-title":"Renew. Energ."},{"key":"10.1016\/j.ijpharm.2018.08.028_b0150","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.biopha.2017.06.038","article-title":"6-shogaol induces autophagic cell death then triggered apoptosis in colorectal adenocarcinoma HT-29 cells","volume":"93","author":"Li","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.ijpharm.2018.08.028_b0155","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.actatropica.2009.12.007","article-title":"Larvicidal activities of ginger (Zingiber officinale) against Angiostrongylus cantonensis","volume":"115","author":"Lin","year":"2010","journal-title":"Acta Trop."},{"issue":"10","key":"10.1016\/j.ijpharm.2018.08.028_b0160","first-page":"1450","article-title":"Tissue distribution study of bromhexine hydrochloride lung-targeting injectable microspheres","volume":"31","author":"Liu","year":"2012","journal-title":"Latin Am. J. Pharm."},{"issue":"9","key":"10.1016\/j.ijpharm.2018.08.028_b0165","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1080\/10717544.2016.1189984","article-title":"Preparation of novel butyryl galactose ester-modified coix component microemulsions and evaluation on hepatoma-targeting in vitro and in vivo","volume":"23","author":"Liu","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijpharm.2018.08.028_b0170","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ijbiomac.2018.01.171","article-title":"A novel IgG1 monoclonal antibody against xanthine oxidase alleviates inflammation induced by potassium oxonate in mice","volume":"112","author":"Liu","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"issue":"5","key":"10.1016\/j.ijpharm.2018.08.028_b0175","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.semarthrit.2014.10.008","article-title":"The effect of initiating pharmacologic insulin on serum uric acid levels in patients with diabetes: a matched cohort analysis","volume":"44","author":"MacFarlane","year":"2015","journal-title":"Sem. Arthrit. Rheumat."},{"key":"10.1016\/j.ijpharm.2018.08.028_b0180","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.biopha.2017.02.066","article-title":"The anti-allergic and anti-inflammatory effects of Benjakul extract (a Thai traditional medicine), its constituent plants and its some pure constituents using in vitro experiments","volume":"89","author":"Makchuchit","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijpharm.2018.08.028_b0185","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.eujim.2017.02.001","article-title":"Determination of the concentration of major active anti-emetic constituents within commercial ginger food products and dietary supplements","volume":"10","author":"Marx","year":"2017","journal-title":"Eur. J. Integr. Med."},{"issue":"6","key":"10.1016\/j.ijpharm.2018.08.028_b0190","first-page":"606","article-title":"In vitro evaluation of anti-Alzheimer effects of dry ginger (Zingiber officinale Roscoe) extract","volume":"52","author":"Mathew","year":"2014","journal-title":"Indian J. Exp. Biol."},{"issue":"2\u20133","key":"10.1016\/j.ijpharm.2018.08.028_b0195","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0169-409X(01)00105-3","article-title":"Solid lipid nanoparticles: production, characterization and applications","volume":"47","author":"Mehnert","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"Suppl 2","key":"10.1016\/j.ijpharm.2018.08.028_b0200","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/annrheumdis-2016-eular.3116","article-title":"THU0525 counting synovial fluid monosodium urate crystals may be useful in the management of patients with gout","volume":"75","author":"Montagna","year":"2016","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.ijpharm.2018.08.028_b0205","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.bbrc.2014.04.121","article-title":"6-Shogaol, an active constituent of ginger, attenuates neuroinflammation and cognitive deficits in animal models of dementia","volume":"449","author":"Moon","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijpharm.2018.08.028_b0210","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ejphar.2016.06.044","article-title":"Pretreatment of 6-shogaol attenuates oxidative stress and inflammation in middle cerebral artery occlusion-induced mice","volume":"788","author":"Na","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ijpharm.2018.08.028_b0220","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.taap.2016.08.019","article-title":"6-Shogaol, an active compound of ginger, alleviates allergic dermatitis-like skin lesions via cytokine inhibition by activating the Nrf2 pathway","volume":"310","author":"Park","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ijpharm.2018.08.028_b0225","first-page":"243","article-title":"Formulation consideration and characterization of microemulsion drug delivery system for transnasal administration of carbamazepine","author":"Patel","year":"2013","journal-title":"Bull. Fac. Pharm., Cairo Univ."},{"issue":"1","key":"10.1016\/j.ijpharm.2018.08.028_b0230","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/jps.10277","article-title":"The effect of lipophilicity of spin-labeled compounds on their distribution in solid lipid nanoparticle dispersions studied by electron paramagnetic resonance","volume":"92","author":"Pegi","year":"2003","journal-title":"J. Pharma. Sci."},{"issue":"1","key":"10.1016\/j.ijpharm.2018.08.028_b0235","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/aps.2014.113","article-title":"Oral delivery of capsaicin using MPEG-PCL nanoparticles","volume":"36","author":"Peng","year":"2015","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ijpharm.2018.08.028_b0240","first-page":"29","article-title":"Novel delivery systems fro drug targeting to the brain","author":"Reddy","year":"2004","journal-title":"Drug. Fut."},{"issue":"5","key":"10.1016\/j.ijpharm.2018.08.028_b0245","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s40273-018-0643-4","article-title":"Cost-effectiveness analysis of lesinurad\/allopurinol versus febuxostat for the management of gout\/hyperuricemia in Italy","volume":"36","author":"Ruggeri","year":"2018","journal-title":"PharmacoEconomics"},{"issue":"1","key":"10.1016\/j.ijpharm.2018.08.028_b0250","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.fct.2009.10.005","article-title":"6-Shogaol inhibits monosodium urate crystal-induced inflammation\u2013an in vivo and in vitro study","volume":"48","author":"Sabina","year":"2010","journal-title":"Food Chem. Toxicol. Int. J. Publish. Br. Indust. Biol. Res. Associat."},{"issue":"7","key":"10.1016\/j.ijpharm.2018.08.028_b0255","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1007\/s10620-016-4086-5","article-title":"Soluble dietary fiber can protect the gastrointestinal mucosa against nonsteroidal anti-inflammatory drugs in mice","volume":"61","author":"Satoh","year":"2016","journal-title":"Digest. Dis. Sci."},{"key":"10.1016\/j.ijpharm.2018.08.028_b0260","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.colsurfb.2015.03.049","article-title":"Sodium alginate-cross-linked polymyxin B sulphate-loaded solid lipid nanoparticles: antibiotic resistance tests and HaCat and NIH\/3T3 cell viability studies","volume":"129","author":"Severino","year":"2015","journal-title":"Colloid. Surf. B, Biointerf."},{"key":"10.1016\/j.ijpharm.2018.08.028_b0265","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jcis.2014.04.057","article-title":"Physicochemical characterization of solid lipid nanoparticles (SLNs) prepared by a novel microemulsion technique","volume":"428","author":"Shah","year":"2014","journal-title":"J. Colloid Interf. Sci."},{"issue":"1\u20132","key":"10.1016\/j.ijpharm.2018.08.028_b0270","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ijpharm.2015.03.070","article-title":"Core-shell structured Fe3O4@TiO2-doxorubicin nanoparticles for targeted chemo-sonodynamic therapy of cancer","volume":"486","author":"Shen","year":"2015","journal-title":"Int. J. Pharmaceut."},{"issue":"1","key":"10.1016\/j.ijpharm.2018.08.028_b0275","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/jphp.12314","article-title":"Realgar nanoparticle-based microcapsules: preparation and in-vitro\/in-vivo characterizations","volume":"67","author":"Shi","year":"2015","journal-title":"J. Pharm. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.ijpharm.2018.08.028_b0280","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ijpharm.2015.07.023","article-title":"Preparation of a micro\/nanotechnology based multi-unit drug delivery system for a Chinese medicine Niuhuang Xingxiao Wan and assessment of its antitumor efficacy","volume":"492","author":"Shi","year":"2015","journal-title":"Int. J. Pharmaceut."},{"issue":"1\u20132","key":"10.1016\/j.ijpharm.2018.08.028_b0285","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.ijpharm.2012.07.058","article-title":"Long-term stability, biocompatibility and oral delivery potential of risperidone-loaded solid lipid nanoparticles","volume":"436","author":"Silva","year":"2012","journal-title":"Int. J. Pharma."},{"issue":"1","key":"10.1016\/j.ijpharm.2018.08.028_b0290","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3109\/03639045.2012.657645","article-title":"In vitro and in vivo evaluation of a novel diltiazem hydrochloride polydispersity sustained-release system","volume":"39","author":"Sun","year":"2013","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpharm.2018.08.028_b0295","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.foodchem.2014.03.039","article-title":"Synthesis and quorum sensing inhibitory activity of key phenolic compounds of ginger and their derivatives","volume":"159","author":"Vijendra Kumar","year":"2014","journal-title":"Food Chem."},{"issue":"1","key":"10.1016\/j.ijpharm.2018.08.028_b0300","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.appet.2010.04.004","article-title":"Development of ginger based ready-to-eat appetizers by response surface methodology","volume":"55","author":"Wadikar","year":"2010","journal-title":"Appetite"},{"issue":"9","key":"10.1016\/j.ijpharm.2018.08.028_b0305","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3109\/1061186X.2014.939983","article-title":"Methazolamide-loaded solid lipid nanoparticles modified with low-molecular weight chitosan for the treatment of glaucoma: vitro and vivo study","volume":"22","author":"Wang","year":"2014","journal-title":"J. Drug Target."},{"issue":"6","key":"10.1016\/j.ijpharm.2018.08.028_b0310","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S1773-2247(13)50083-9","article-title":"Plga microspheres as a delivery vehicle for sustained release of tetracycline: biodistribution in mice after subcutaneous administration","volume":"23","author":"Wang","year":"2013","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"1\u20132","key":"10.1016\/j.ijpharm.2018.08.028_b0315","article-title":"A novel formulation of [6]-gingerol: Proliposomes with enhanced oral bioavailability and antitumor effect","volume":"535","author":"Wang","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.08.028_b0320","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejpb.2013.08.013","article-title":"Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) for pulmonary application: a review of the state of the art","volume":"86","author":"Weber","year":"2014","journal-title":"Eur. J. Pharma. Biopharma."},{"key":"10.1016\/j.ijpharm.2018.08.028_b0325","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jep.2005.05.043","article-title":"Cytotoxic and apoptotic activities of diarylheptanoids and gingerol-related compounds from the rhizome of Chinese ginger","volume":"102","author":"Wei","year":"2005","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ijpharm.2018.08.028_b0330","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s13346-016-0279-x","article-title":"Formation of microemulsions for using as cosmeceutical delivery systems: effects of various components and characteristics of some formulations","volume":"6","author":"Wuttikul","year":"2016","journal-title":"Drug Deliv. Transl. Re."},{"key":"10.1016\/j.ijpharm.2018.08.028_b0335","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jep.2013.09.024","article-title":"Study on the correlation between constituents detected in serum from Rhizoma Smilacis Glabrae and the reduction of uric acid levels in hyperuricemia","volume":"150","author":"Xu","year":"2013","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ijpharm.2018.08.028_b0340","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.biopha.2017.10.084","article-title":"6-Shogaol ameliorates diabetic nephropathy through anti-inflammatory, hyperlipidemic, anti-oxidative activity in db\/db mice","volume":"97","author":"Xu","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.ijpharm.2018.08.028_b0345","first-page":"5","article-title":"solid lipid nanoparticles a review","volume":"3","author":"Yadav","year":"2016","journal-title":"Journal of Critical reviews"},{"key":"10.1016\/j.ijpharm.2018.08.028_b0350","first-page":"5067","article-title":"Enhanced oral bioavailability of a sterol-loaded microemulsion formulation of Flammulina velutipes, a potential antitumor drug","volume":"7","author":"Yi","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpharm.2018.08.028_b0355","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13075-018-1546-7","article-title":"Mice with miR-146a deficiency develop severe gouty arthritis via dysregulation of TRAF 6, IRAK 1 and NALP3 inflammasome","volume":"Vol. 20","author":"Zhang","year":"2018","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.ijpharm.2018.08.028_b0360","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ijpharm.2017.10.040","article-title":"Solid lipid nanoparticles as carriers for oral delivery of hydroxysafflor yellow A","volume":"535","author":"Zhao","year":"2018","journal-title":"Int. J. Pharmaceut."},{"issue":"4","key":"10.1016\/j.ijpharm.2018.08.028_b0365","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s12272-014-0481-7","article-title":"Improved oral bioavailability of capsaicin via liposomal nanoformulation: preparation, in vitro drug release and pharmacokinetics in rats","volume":"38","author":"Zhu","year":"2015","journal-title":"Arch. Pharmacal Res."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517318306069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517318306069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:34:03Z","timestamp":1759916043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517318306069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":70,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0378517318306069"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2018.08.028","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced oral bioavailability and anti-gout activity of [6]-shogaol-loaded solid lipid nanoparticles","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2018.08.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}